Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis

NCT02975206 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Atopic Dermatitis

Interventions

DRUG: Serlopitant High Dose
DRUG: Placebo Oral Tablet
DRUG: Serlopitant Low Dose

Sponsor

Vyne Therapeutics Inc.